image
Healthcare - Biotechnology - NASDAQ - US
$ 0.6802
-5.25 %
$ 4.47 M
Market Cap
-0.24
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
22.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Adial Pharmaceuticals, Inc.
image
ADIL has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ADIL

image
$100.0m$100.0m$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ADIL

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)($18.0m)($18.0m)($20.0m)($20.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ADIL

image
$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)20232023202420242025202520262026202720272028202820292029